NASA Develops IV Fluid Technology for Space, Enabling Deep Space Human Missions
Summary: NASA is developing a system capable of producing intravenous (IV) fluids in microgravity to address the challenge of storing liquid medications during long-duration deep space missions lasting up to three years. This technology could provide critical medical support for Artemis lunar missions and beyond.
Credit: NASA
Currently, astronauts on near-Earth orbit missions rely on regular resupply from Earth for IV medications. However, during lunar or Mars missions, crew members will be out of contact with Earth for extended periods, making stable supply of IV medications a critical challenge. NASA's IVGEN-Mini system prototype, developed at NASA's Goddard Space Flight Center, aims to produce pure water using the existing water purification system on the space station and manufacture IV fluids on-site, eliminating the need to launch large quantities of liquid medications.
If successfully validated, this system would allow astronauts to self-produce IV fluids in deep space, significantly enhancing mission autonomy and medical capabilities.